Interactions among Vascular-Tone Modulators Contribute to High Altitude Pulmonary Edema and Augmented Vasoreactivity in Highlanders

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Ali, Zahara ^a,b   Mishra, Aastha ^a,b   Kumar, Rahul ^a   Alam, Perwez ^a,b   Pandey, Priyanka ^a,b   Ram, Rekhbala ^a   Thinlas, Tashi ^c   Mohammad, Ghulam ^c   Pasha, M A Qadar ^a,b  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b UNIVERSITY OF PUNE   (India)

^c SNM Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISO PROSTAGLANDIN F2 ALPHA; ALDOSTERONE; BIOLOGICAL MARKER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; PROSTAGLANDIN F2 ALPHA; RENIN; SEROTONIN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ADULT; ALDOSTERONE BLOOD LEVEL; ALTITUDE ACCLIMATIZATION; ALTITUDE DISEASE; ARTERIAL OXYGEN SATURATION; ARTICLE; BREATHING RATE; CONTROLLED STUDY; CYTOCHROME P450 FAMILY 11 SUBFAMILY B POLYPEPTIDE 2 GENE; DIASTOLIC BLOOD PRESSURE; DISEASE MARKER; DOWN REGULATION; ENDOTHELIN 1 GENE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GENE; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; LUNG EDEMA; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; NITRIC OXIDE SYNTHASE 3 GENE; OXYGEN SATURATION; PATHOGENESIS; PLASMA RENIN ACTIVITY; PULSE RATE; RENIN GENE; SUPEROXIDE DISMUTASE GENE; SYSTOLIC BLOOD PRESSURE; TRYPTOPHAN HYDROXYLASE 1 GENE;

ADULT; ALTITUDE; ALTITUDE SICKNESS; ANOXIA; BIOLOGICAL MARKERS; BLOOD VESSELS; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION, PULMONARY; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84866269593     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044049     Document Type: Article

References (46)

1. Hackett PH, Roach RC, (2001) High-Altitude Illness. N Engl J Med 345: 107-114.
2. Beall CM, (2007) Detecting natural selection in high-altitude human populations. Respir Physiol Neurobiol 158: 161-171.
3. Moore LG, Niermeyer S, Zamudio S, (1998) Human adaptation to high altitude: regional and life-cycle perspectives. Am J Phys Anthropol 41: 25-64.
4. Basnyat B, Murdoch DR, (2003) High-altitude illness. Lancet 361: 1967-1974.
5. León-Velarde F, Villafuerte FC, Richalet JP, (2010) Chronic mountain sickness and the heart. Prog Cardiovasc Dis 52: 540-549.
6. Skoro-Sajer N, Mittermayer F, Panzenboeck A, Bonderman D, Sadushi R, et al. (2007) Asymmetric dimethylarginine is increased in chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 176: 1154-1160.
7. Zakrzewicz D, Eickelberg O, (2009) From arginine methylation to ADMA: a novel mechanism with therapeutic potential in chronic lung diseases. B M C Pulm Med 9: 5.
8. Arrigoni FI, Vallance P, Haworth SG, Leiper JM, (2003) Metabolism of asymmetric dimethylarginines is regulated in the lung developmentally and with pulmonary hypertension induced by hypobaric hypoxia. Circulation 107: 1195-1201.
9. Vallance P, Leiper J, (2004) Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol 24: 1023-1030.
10. Eddahibi S, Fabre V, Boni C, Martres MP, Raffestin B, et al. (1999) Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin. Circ Res 84: 329-336.
11. Herve P, Launay JM, Scrobohaci ML, Brenot F, Simonneau G, et al. (1995) Increased plasma serotonin in primary pulmonary hypertension. Am J Med 99: 249-254.
12. Montuschi P, Barnes PJ, Roberts II LJ, (2004) Isoprostanes: markers and mediators of oxidative stress. FASEB J 18: 1791-1800.
13. Morrow JD, Roberts LJ, (2002) The isoprostanes: their role as an index of oxidative stress status in human pulmonary disease. Am J Respir Crit Care Med 166: S25-S30.
14. Charu R, Stobdan T, Ram RB, Khan AP, Qadar Pasha MA, (2006) Susceptibility to high-altitude pulmonary oedema: role of ACE and ET-1 polymorphisms. Thorax 61: 1011-1012.
15. Sartori C, Vollenweider L, Löffler BM, Delabays A, Nicod P, et al. (1999) Exaggerated endothelin release in high-altitude pulmonary edema. Circulation 99: 2665-2668.
16. Droma Y, Hayano T, Takabayashi Y, Koizumi T, Kubo K, et al. (1996) Endothelin-1 and interleukin-8 in high altitude pulmonary oedema. Eur Respir J 9: 1947-1949.
17. MacGregor GA, Markandu ND, Roulston JE, Jones JC, Morton JJ, (1981) Maintenance of blood pressure by the renin-angiotensin system in normal man. Nature 291: 329-331.
18. Rock PB, Kraemer WJ, Fulco CS, Trad LA, Malconian MK, et al. (1993) Effects of altitude acclimatization on fluid regulatory hormone response to submaximal exercise. J Appl Physiol 75: 1208-1215.
19. Milledge JS, Catley DM, (1982) Renin, aldosterone, and converting enzyme during exercise and acute hypoxia in humans. J Appl Physiol 52: 320-323.
20. Busch T, Bärtsch P, Pappert D, Grünig E, Elser H, et al. (2001) Hypoxia decreases exhaled nitric oxide in mountaineers susceptible to high altitude pulmonary edema. Am J Respir Crit Care Med 163: 368-373.
21. Beall CM, Laskowski D, Strohl KP, Soria R, Villena M, et al. (2001) Pulmonary nitric oxide in mountain dwellers. Nature 414: 411-412.
22. Nakanishi K, Tajima F, Nakamura A, Yagura S, Ookawara T, et al. (1995) Antioxidant system in hypobaric-hypoxia. J Physiol 489: 869-876.
23. Dosek A, Ohno H, Acs Z, Taylor AW, Radak Z, (2007) High altitude and oxidative stress. Respir Physiol Neurobiol 158: 128-131.
24. Moncada S, Higgs A, (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012.
25. Cooke JP, Dzau VJ, (1997) Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases. Circulation 96: 379-382.
26. Suda O, Tsutsui M, Morishita T, Tasaki H, Ueno S, et al. (2004) Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress. Arterioscler Thromb Vasc Biol 24: 1682-1688.
27. Qadar Pasha MA, Khan AP, Kumar R, Grover SK, Ram RB, et al. (2001) Angiotensin converting enzyme insertion allele in relation to high altitude adaptation. Ann Hum Genet 65: 531-536.
28. Struthers AD, MacDonald TM, (2004) Review of aldosterone-and angiotensin II-induced target organ damage and prevention. Cardiovasc Res 61: 663-670.
29. Lemarié CA, Paradis P, Schiffrin EL, (2008) New insights on signaling cascades induced by cross-talk between angiotensin II and aldosterone. J Mol Med 86: 673-678.
30. Linz W, Wohlfart P, Schölkens BA, Malinski T, Wiemer G, (1999) Interactions among ACE, kinins and NO. Cardiovasc Res. 43: 549-561.
31. Mishra A, Ali Z, Vibhuti A, Kumar R, Alam P, et al. (2011) CYBA and GSTP1 variants associate with oxidative stress under hypobaric hypoxia as observed in high-altitude pulmonary edema. Clin Sci 122: 299-309.
32. Jefferson JA, Simoni J, Escudero E, Hurtado ME, Swenson ER, et al. (2004) Increased oxidative stress following acute and chronic high altitude exposure. High Alt Med Biol 5: 61-69.
33. Marcos E, Fadel E, Sanchez O, Humbert M, Dartevelle P, et al. (2004) Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension. Circ Res 94: 1263-1270.
34. Königshoff M, Dumitrascu R, Udalov S, Amarie OV, Reiter R, et al. (2010) Increased expression of 5-hydroxytryptamine2A/B receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention. Thorax 65: 949-955.
35. MacLean MR, (2007) Pulmonary hypertension and the serotonin hypothesis: where are we now? Int J Clin Pract Suppl 61: 27-31; 2007.
36. Lee SL, Wang WW, Fanburg BL, (1998) Superoxide as an intermediate signal for serotonin-induced mitogenesis. Free Radic Biol Med 24: 855-858.
37. Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, et al. (2009) Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 54: S20-31.
38. Gorenflo M, Zheng C, Werle E, Fiehn W, Ulmer HE, (2001) Plasma levels of asymmetrical dimethyl-L-arginine in patients with congenital heart disease and pulmonary hypertension. J Cardiovasc Pharmacol 37: 489-492.
39. Kielstein JT, Bode-Böger SM, Hesse G, Martens-Lobenhoffer J, Takacs A, et al. (2005) Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension. Arterioscler Thromb Vasc Biol 25: 1414-1418.
40. Berger MM, Dehnert C, Bailey DM, Luks AM, Menold E, et al. (2009) Transpulmonary plasma ET-1 and nitrite differences in high altitude pulmonary hypertension. High Alt Med Biol 10: 17-24.
41. Rajput C, Najib S, Norboo T, Afrin F, Qadar Pasha MA, (2006) Endothelin-1 gene variants and levels associate with adaptation to hypobaric hypoxia in high-altitude natives. Biochem Biophys Res Commun 341: 1218-1224.
42. Ahsan A, Charu R, Norboo T, Afrin F, Baig MA, et al. (2004) eNOS allelic variants at the same locus associate with HAPE and adaptation. Thorax 59: 1000-1002.
43. Qadar Pasha MA, Kocherlakota KS, Khan AP, Norboo T, Grover SK, et al. (2003) Arterial oxygen saturation under hypoxic environment of high-altitude associates with routine physical activities of natives. Current Science 85: 502-506.
44. Aggarwal S, Negi S, Jha P, Singh PK, Stobdan T, et al. (2010) EGLN1 involvement in high-altitude adaptation revealed through genetic analysis of extreme constitution types defined in Ayurveda. Proc Natl Acad Sci U S A 107: 18961-18966.
45. Simonson TS, Yang Y, Huff CD, Yun H, Qin G, et al. (2010) Genetic evidence for high-altitude adaptation in Tibet. Science 329: 72-75.
46. Beall CM, Cavalleri GL, Deng L, Elston RC, Gao Y, et al. (2010) Natural selection on EPAS1 (HIF2alpha) associated with low hemoglobin concentration in Tibetan highlanders. Proc Natl Acad Sci U S A 22; 107: 11459-11464.